Table 3 Summary of IPA analysis based on rs3219175 associated plasma analytes.
Top Canonical pathways | p value | Overlapping genes | Genes |
|---|---|---|---|
HMGB1 pathway | 9.26E-10 | 4.2% 5/118 | AGER, TGFB1, TGFB2, TNFRSF1A, TNFRSF1B |
Hepatic Fibrosis/Stellate Cell Activation | 3.68E-09 | 3.2% 5/155 | VEGFR2, TGFB1, TGFB2, TNFRSF1A, TNFRSF1B |
p38 MAPK Signaling | 9.78E-08 | 4.0% 4/101 | TGFB1, TGFB2, TNFRSF1A, TNFRSF1B |
Hepatic Cholestasis | 3.06E-07 | 3.0% 4/134 | TGFB1, TGFB2, TNFRSF1A, TNFRSF1B |
Tight Junction Signaling | 3.25E-07 | 2.9% 4/136 | TGFB1, TGFB2, TNFRSF1A, TNFRSF1B |
Top Diseases and Bio Functions | p-value | Molecules | |
Inflammatory Response | 3.84E-02–6.78E-07 | 4 | |
Endocrine System Disorders | 2.05E-03–8.13E-06 | 2 | |
Gastrointestinal Disease | 2.05E-03–8.13E-06 | 2 | |
Metabolic Disease | 2.05E-03–8.13E-06 | 2 |